Development and implementation of new healthcare technologies in the Russian Federation: expert assessment and prospects for improvement

Rukavitsyna N.P., Gudimenko E.E., Rumyantseva E.I., Lukyantseva D.V., Bogdanova V.O., Usacheva N.E.

1) Center for Expertise and Quality Control of Medical Care, Moscow, Russia; 2) Russian Medical Academy of Continuous Professional Education, Moscow, Russia; 3) “Circle of Kindness” Foundation for Supporting Children with Severe Life-Threatening and Chronic Diseases, Including Rare (Orphan) Diseases, Moscow, Russia; 4) National Medical Research Center for Endocrinology named after Academician I.I. Dedov, Moscow, Russia

Objective: Assessment of the current conditions and prospective areas for improving the mechanisms for developing and implementing new healthcare technologies (HT) in the Russian Federation, based on an analysis of the opinions of specialists involved in this field.
Materials and methods: A survey was conducted among 237 specialists (mean experience in HT development: 9.3 years) representing research institutes (52%), medical organizations (15.5%), government authorities, and private developer companies. The 37-question survey covered topics such as state support, funding, regulatory frameworks, the institutional environment, and specific characteristics of the technology lifecycle stages.
Results: In addition to identifying current achievements in supporting the development and implementation of new HT, the study highlighted key areas for the industry’s further development. According to the respondents, financial instruments are the most sought-after form of support (87.3%). Moreover, more than half of the respondents already utilize state funding programs (56.6%) and grant support (56.9%). An analysis of the technology lifecycle confirmed the need for targeted support at the pre-registration stage (57.9% noted a need for funding) and the market entry stage (the difficulty of recouping investments was rated at an average of 7 out of 10, where 10 represents the highest level of difficulty). Promising areas for improving the regulatory environment include the implementation of expedited registration procedures («green channels») and the development of public-private partnership mechanisms. Optimizing administrative procedures was also identified as a priority area for improvement (average rating of 7 out of 10).
Conclusion: The findings reflect global trends in technology development and confirm the relevance of measures implemented by the Ministry of Health of the Russian Federation. The study results outline the necessary direction for further improving regulatory procedures, fostering interdisciplinary collaborations, and enhancing the effectiveness of financial instruments, taking into account best international practices and achievements already made at the national level.

For citations: Rukavitsyna N.P., Gudimenko E.E., Rumyantseva E.I., Lukyantseva D.V., Bogdanova V.O., Usacheva N.E. Development and implementation of new healthcare technologies in the Russian Federation: expert assessment and prospects for improvement. Pharmateca. 2026;33(6):132-142. (In Russ.). DOI: https://dx.doi.org/10.18565/pharmateca.2026.6.132-142

Authors’ contribution: Rukavitsyna N.P. – study concept and design, drafting the article, editing, manuscript preparation for publication. Gudimenko  E.E. – study concept and design, drafting the article, editing, manuscript preparation for publication. Rumyantseva E.I. – data analysis, drafting the text. Lukyantseva D.V. – editing. Bogdanova V.O. – editing. Usacheva N.E. – editing.
Conflicts of interest: The authors confirm that they have no conflicts of interest to declare.
Funding: The study was conducted without any sponsorship.
Authors’ Data Sharing Statement: The data supporting the findings of this study are available upon request from the corresponding author after approval from the principal investigator.

Keywords

About the Authors

Nadezhda P. Rukavitsyna, Cand. Sci. (Pharm.), Head of the Department for Innovation Implementation Support and Information Technologies, Center for Expertise and Quality Control of Medical Care, Moscow; Associate Professor, Department of Healthcare Organization and Public Health with a Course on Health Technology Assessment, Russian Medical Academy of Continuous Professional Education, Moscow, Russia;
rukavitsyna@rosmedex.ru, ORCID: https://orcid.org/0009-0001-5706-9012, eLibrary SPIN: 7433-7774 (corresponding author)
Ekaterina E. Gudimenko, Deputy Head of the Department for Development and External Communications, Center for Expertise and Quality Control of Medical Care, Moscow, Russia; gudimenko@rosmedex.ru, ORCID: https://orcid.org/0009-0001-5351-7789
Elizaveta I. Rumyantseva, Cand. Sci. (Med.), Leading Specialist, Department for Support of New Remuneration Systems and Department of Medical Care Payment Methods, Center for Expertise and Quality Control of Medical Care, Moscow, Russia; rumyantseva@rosmedex.ru, ORCID:
https://orcid.org/0000-0002-4935-4139, eLibrary SPIN: 3826-1535
Darya V. Lukyantseva, Cand. Sci. (Med.), Head of the Department for Clinical Testing and Innovation Assessment, Center for Expertise and Quality Control of Medical Care, Moscow, Russia; Associate Professor, Department of Healthcare Organization and Public Health with a Course on Health Technology Assessment Russian Medical Academy of Continuous Professional Education, Moscow, Russia; Lukyantseva@rosmedex.ru, ORCID: https://orcid.org/0000-0001-9892-1147, WoS ResearcherID: X-3920-2019, eLibrary SPIN: 4858-1818
Valeriya O. Bogdanova, Cand. Sci. (Med.), Medical Director of the «Circle of Kindness» Foundation (supporting children with severe life-threatening and chronic diseases, including rare/orphan diseases); Clinical Pharmacologist, General Clinical Department, Endocrinology Research Centre, Moscow; Associate Professor, Department of Healthcare Organization and Public Health with a Course on Health Technology Assessment, Russian Medical Academy of Continuous Professional Education, Moscow, Russia; Valeriya.bar@mail.ru, ORCID: https://orcid.org/0000-0001-7762-7854, Scopus Author ID: 57197766266, eLibrary SPIN 9620-1989
Natalya E. Usacheva, Cand. Sci. (Pharm.), Deputy Head of the Department for Methodology of Clinical Guideline Development and Expert Assessment, Center for Expertise and Quality Control of Medical Care, Moscow, Russia; usacheva@rosmedex.ru, ORCID: https://orcid.org/0000-0002-4416-4344, Scopus Author ID: 57223937739